7-Benzyl-4-(2-methylbenzyl)-1,2,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5(4H)-one (BioDeep_00000837738)
代谢物信息卡片
化学式: C24H26N4O (386.2106506)
中文名称:
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: CC1=CC=CC=C1CN2C(=O)C3=C(CCN(C3)CC4=CC=CC=C4)N5C2=NCC5
InChI: InChI=1S/C24H26N4O/c1-18-7-5-6-10-20(18)16-28-23(29)21-17-26(15-19-8-3-2-4-9-19)13-11-22(21)27-14-12-25-24(27)28/h2-10H,11-17H2,1H3
描述信息
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor
C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C174048 - ERK Inhibitor
C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C155764 - AKT Inhibitor
D000970 - Antineoplastic Agents
同义名列表
数据库引用编号
5 个数据库交叉引用编号
- PubChem: 73777259
- DrugBank: DB14844
- ChEMBL: CHEMBL4297310
- CAS: 1342897-86-2
- CAS: 1616632-77-9
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Masayuki Yamaji, Akinobu Ota, Md Wahiduzzaman, Sivasundaram Karnan, Toshinori Hyodo, Hiroyuki Konishi, Shinobu Tsuzuki, Yoshitaka Hosokawa, Masayuki Haniuda. Novel ATP-competitive Akt inhibitor afuresertib suppresses the proliferation of malignant pleural mesothelioma cells.
Cancer medicine.
2017 Nov; 6(11):2646-2659. doi:
10.1002/cam4.1179. [PMID: 28960945] - Mark N Stein, Joseph R Bertino, Howard L Kaufman, Tina Mayer, Rebecca Moss, Ann Silk, Nancy Chan, Jyoti Malhotra, Lorna Rodriguez, Joseph Aisner, Robert D Aiken, Bruce G Haffty, Robert S DiPaola, Tracie Saunders, Andrew Zloza, Sherri Damare, Yasmeen Beckett, Bangning Yu, Saltanat Najmi, Christian Gabel, Siobhan Dickerson, Ling Zheng, Wafik S El-Deiry, Joshua E Allen, Martin Stogniew, Wolfgang Oster, Janice M Mehnert. First-in-Human Clinical Trial of Oral ONC201 in Patients with Refractory Solid Tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2017 Aug; 23(15):4163-4169. doi:
10.1158/1078-0432.ccr-16-2658. [PMID: 28331050] - Yuan Feng, Jihong Zhou, Zhanhua Li, Ying Jiang, Ying Zhou. Small Molecular TRAIL Inducer ONC201 Induces Death in Lung Cancer Cells: A Preclinical Study.
PloS one.
2016; 11(9):e0162133. doi:
10.1371/journal.pone.0162133. [PMID: 27626799] - Joshua E Allen, Gabriel Krigsfeld, Patrick A Mayes, Luv Patel, David T Dicker, Akshal S Patel, Nathan G Dolloff, Evangelos Messaris, Kimberly A Scata, Wenge Wang, Jun-Ying Zhou, Gen Sheng Wu, Wafik S El-Deiry. Dual inactivation of Akt and ERK by TIC10 signals Foxo3a nuclear translocation, TRAIL gene induction, and potent antitumor effects.
Science translational medicine.
2013 Feb; 5(171):171ra17. doi:
10.1126/scitranslmed.3004828. [PMID: 23390247]